 
        Greater pain and functional improvement with highly- versus moderately-crosslinked HA in knee OA
 
                                                    Greater pain and functional improvement with highly- versus moderately-crosslinked HA in knee OA
A pilot study to compare two different hyaluronic acid compounds for treatment of knee osteoarthritis.
Int J Immunopathol Pharmacol. 2012 Oct-Dec;25(4):1093-8Synopsis
20 patients with bilateral knee osteoarthritis were administered two intraarticular injections of Variofill in the right knee and two intraarticular injections of Hylan G-F 20 in the left knee. Patients were assessed for treatment response on a Visual Analog Scale for pain and the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) after 3 and 6 months. Comparative efficacy was ...
                To view the full content, login to your account,
or start your 30-day FREE Trial today.
            
            FREE TRIAL
            LOGIN
            Forgot Password?
    Explore some of our unlocked ACE Reports below!
 
                Learn about our AI Driven 
 High Impact Search Feature
     
    Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.
Continue 
                     
                 
                                                         
                                                         
                                                         
                                                         
                                                         
                                                         
                                                         
                                                         
                                                         
                                                         
                                                         
                                                         
                                                         
                                                         LOGIN
                                    LOGIN
                                 
            
Join the Conversation
Please Login or Join to leave comments.